On June 10, 2026, Chae Kyu-han, Deputy Director General for Narcotics Safety Planning at the Ministry of Food and Drug Safety, accompanied by a delegation, visited Neocannbio’s production center in Andong. During their visit, the group toured the construction site of Korea's first medical cannabis active pharmaceutical ingredient (API) manufacturing facility (bGMP), currently being established by the company, and viewed the company's proprietary TPC-MW equipment.